$AEMD "We are truly grateful that our colleagues at the Boston University CTE Center have expanded our opportunity to validate our Tausome™ biomarker as a candidate to detect and monitor CTE in living individuals," stated Jim Joyce, Executive Chairman at Exosome Sciences and Chairman and CEO of Aethlon Medical. #AEMD, #ConcussionMovie,



http://stockpumpers.blogspot.com/2016/01/aeth...es-to.html